Conference Proceedings

Safety and tolerability of tildrakizumab in patients with chronic plaque psoriasis: Results from long-term extensions of 2 phase 3 studies

K Reich, A Blauvelt, D Thaci, KA Papp, A Kimball, R Sinclair, S Tyring, N Cichanowitz, Q Li, S Green, C La Rosa

AUSTRALASIAN JOURNAL OF DERMATOLOGY | WILEY | Published : 2018